메뉴 건너뛰기




Volumn 48, Issue 3, 2001, Pages 255-258

Cisplatin and escalating doses of paclitaxel and epirubicin in advanced ovarian cancer. A phase I study

Author keywords

Advanced ovarian cancer; Epirubicin; Ovarian cancer; Taxol

Indexed keywords

CISPLATIN; EPIRUBICIN; PACLITAXEL;

EID: 0034884286     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800000271     Document Type: Article
Times cited : (4)

References (16)
  • 3
    • 0022568787 scopus 로고
    • Treatment of advanced ovarian cancer. A randomized trial comparing Adriamycin or 4′-epi-adriamycin in combination with cisplatin and cyclophosphamide
    • (1986) Med Pediatr Oncol , vol.14 , pp. 26
    • Bezwoda, W.R.1
  • 7
    • 0032517581 scopus 로고    scopus 로고
    • ICON2: Randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer
    • International Collaborative Ovarian Neoplasm Study
    • (1998) Lancet , vol.352 , pp. 1571
  • 11
    • 0025861545 scopus 로고
    • Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma. A meta-Analysis
    • (1991) J Clin Oncol , vol.9 , pp. 1668


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.